OCUL holder plans Rule 144 sale of 7,863 shares

A shareholder of OCUL has filed a notice of proposed sale under Rule 144 for 7,863 shares of common stock.

Accepted by SEC EDGAR 02/12/2026 - 04:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder of OCUL has filed a notice of proposed sale under Rule 144 for 7,863 shares of common stock. The shares have an aggregate market value of $71,082.31 and are intended to be sold on NASDAQ around 02/12/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

The securities were acquired on 02/11/2026 as restricted stock vesting under a registered plan from the issuer, in the same amount of 7,863 shares, with no separate cash payment listed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the OCUL Form 144 filing disclose about planned share sales?

The Form 144 discloses a plan to sell 7,863 OCUL common shares with an aggregate market value of $71,082.31. The planned sale is on NASDAQ around 02/12/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

How were the OCUL shares in this Rule 144 notice originally acquired?

The 7,863 OCUL common shares were acquired on 02/11/2026 through restricted stock vesting under a registered plan from the issuer. The filing identifies the issuer as the source, and the nature of payment is listed as Not Applicable.

What is the aggregate market value of OCUL shares covered by this Form 144?

The filing shows an aggregate market value of $71,082.31 for the 7,863 OCUL common shares to be sold. This figure reflects the market value used for the notice and is tied to the proposed Rule 144 sale on NASDAQ.

Which broker is handling the proposed OCUL Rule 144 share sale?

The planned sale of 7,863 OCUL common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, listed at 1 New York Plaza, 8th Floor, New York, NY 10004. This broker is named as the intermediary for the NASDAQ transaction.

When are the OCUL shares described in the Form 144 expected to be sold?

The notice lists an approximate date of sale of 02/12/2026 for the 7,863 OCUL common shares. This date follows the 02/11/2026 restricted stock vesting and is the target timing for the Rule 144 sale on NASDAQ.

How many OCUL shares are outstanding in relation to this planned Rule 144 sale?

The filing reports 217,691,779 OCUL common shares outstanding as a reference figure. The planned Rule 144 sale covers 7,863 shares, providing context for the size of the proposed transaction relative to total shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002023884
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OCULAR THERAPEUTIX, INC.
SEC File Number	001-36554
Address of Issuer	15 Crosby Drive Bedford MASSACHUSETTS 01730
Phone	781-357-4000
Name of Person for Whose Account the Securities are To Be Sold	NADIA K. WAHEED
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7863	71082.31	217691779	02/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2026	Restricted stock vesting under a registered plan	ISSUER			7863	02/11/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Nadia Waheed
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)